Additional European Equity News

Bayer (BAYN GY) - Co. and Kumquat Biosciences have entered a global exclusive licence and collaboration in precision oncology; focus on developing a Kras G12D Inhibitor Kumquat to receive total payment of up to USD 1.3bln (Newswires)

Bellway (BWY LN) - FY (GBP): Revenue 2.76bln, +17% Y/Y. For FY26, expects to maintain broadly flat avg. outlet number. (Newswires) 

Entain (ENT LN) - H1 (GBP):  EBITDA 583mln, +11% Y/Y, NGR 2.62bln (prev. 2.55bln Y/Y), Revenue 2.59bln (prev. 2.52bln Y/Y). Introduces FY25 EBITDA guidance in the range of GBP 1.1-1.15bln. H1 performance supports upgraded expectation of about 7% online NGR growth on constant currency basis. Highlights that H2 has started well, in line with upgraded guidance. On 12 August, Pierre Bouchut was appointed as permanent non-executive Chair. (Newswires) 

Page (PAGE LN) - H1 (GBP): Revenue 798.4mln (prev. 898mln Y/Y). Announced interim dividend of 5.36p/shr, in line with 2024. (Newswires) 

UBS (UBSG SW) - A bookrunner said share sale priced at CHF 31.46 (Newswires)